The human embryonic stem cells are obtained from the human fetal tissue and undifferentiated inner mass cell of the human embryo. The human embryonic stem cell has the ability to replicate indefinitely and form non-regenerative tissue like myocardial and neural cells. Human embryonic stem cells have the ability to provide an unlimited amount of tissue for transplantation therapies to treat a variety of degenerative diseases because of their potential. As a result, human embryonic stem cells are employed to treat a variety of diseases, including Alzheimer's disease, cancer, blood disorders, immune system disorders, and others.
MARKET SCOPE
The "Global Human Embryonic Stem Cells (hESC) Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the human embryonic stem cells (hESC) market with detailed market segmentation by type and application. The report provides key statistics on the market status of the leading human embryonic stem cells (hESC) market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on type the market is segmented as, Totipotent stem cell, pluripotent stem cell and unipotent stem cells.
- Based on application the market is segmented as, regenerative medicine, stem cell biology research, tissue engineering and toxicology testing.
MARKET DYNAMICS
Drivers:
- Increasing prevalence of chronic and neurological disorders is the key driving factor for the market growth.
- Increasing awareness among people about therapeutic benefits of preserving embryonic stem cells.
- Emerging stem bank services to preserve stem cells is expected to create significant opportunities for market growth.
Restraints:
- However, high cost associated with preserving human embryonic stem cells, stringent regulatory framework, ethical issues are all likely to hamper market growth.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The human embryonic stem cells (hESC) market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the human embryonic stem cells (hESC) market in these regions.
IMPACT OF COVID-19 ON HUMAN EMBRYONIC STEM CELLS (HESC) MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the human embryonic stem cells (hESC) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from human embryonic stem cells (hESC) market are anticipated to lucrative growth opportunities in the future with the rising demand for human embryonic stem cells (hESC) in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the human embryonic stem cells (hESC) market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Thermo Fisher Scientific, Inc
- CellGenix GmbH
- ESI BIO
- PromoCell GmbH
- Lonza
- Cryo-Cell International
- LifeCell
- International Stem Cell Corporation.
- R and D Systems, Inc.
- Takara Bio Inc